Abstract:Objective To investigate the impact of left ejection fraction( LVEF) on the long-term prognosis in patients with coronary artery disease( CAD) who undergoing percutaneous coronary intervention( PCI) , and evaluate the predictive ability of LVEF combined with GRACE scores for long-term prognosis. Methods OPT-CAD registry is a prospective,large-scale,multicenter,registered clinical study. In this analysis,a total of 8347 patients undergoing PCI were selected from OPT-CAD registry,including normal LVEF group (LVEF>50%,n=7444) and reduced LVEF group(LVEF<50%,n=903). The primary endpoint was the patient-oriented composite endpoint(PoCE) 24 months after PCI including all-cause death,myocardial infarction,ischemic stroke and/or any revascularization. Secondary endpoint for PCI patients with postoperative ischemic events in the 24 months( including cardiac death,myocardial infarction and/or ischemic stroke of the composite endpoint) and independent components,all cause of death,ischemia driven reascularization and bleeding on the basis of academic research federation definition ( BARC ) major bleeding events ( BARC 3-5 ) . Results (1) Before propensity score matching:compared with the normal LVEF group,24 months PoCE events in the reduced LVEF group increased significantly,and the difference was statistically significant(P <0. 05). In the secondary endpoint study,compared with the normal LVEF group,the risk of ischemic events and all-cause death,cardiac death and myocardial infarction in the reduced LVEF group were significantly increased(P<0. 05). The stroke,ischemic driven reascularization and major bleeding events compared between the two groups,there was no statistically significant difference(P>0. 05). (2)After propensity score matching:the incidence of 24 months PoCE events in the reduced LVEF group was higher than that in the normal LVEF group(P<0. 05). In the secondary endpoint study,compared with the normal LVEF group,the risk of ischemic events,all-cause death,cardiac death and myocardial infarction 24 hours after surgery significantly increased in the reduced LVEF group(P<0. 05). There was no statistically significant difference between the two groups in the incidence of major bleeding events,stroke or ischemic driven revascularization(P>0. 05). Conclusion The CAD patients combined with reduced LVEF after PCI has a worse prognosis due to the evidently higher risk of all-cause death,cardiac death and myocardial infarction. The optimal long-standing efforts to improve outcomes in patients with reduced LVEF required more studies to investigate.

Clinical prognosis of optimal medical therapy after percutaneous coronary intervention in patients with coronary heart disease

Clinical Outcomes and Risk Factors of Coronary Artery Aneurysms after Successful Percutaneous Coronary Intervention and Drug-Eluting Stent Implantation for Chronic Total Occlusions

Long-term Outcome Comparison of Ostial/shaft Lesions in Unprotected Left Main Coronary Artery Treated by PCI or CABG

The Application Status of Optimal Medical Therapy after Percutaneous Coronary Intervention and Its Influence on Prognosis

Effect of PCI on Clinical Prognosis of Chronic Coronary Artery Occlusion

Clinical effect of postconditioning in ST-elevation myocardial infarction patients treated with primary percutaneous coronary intervention: a meta-analysis of randomized controlled trials.

Long-term Outcome Analysis of Patients Underwent Percutaneous Coronary Intervention with Prior Ischemic Stroke

Retraction Note: Meta-analysis of the Effect of Percutaneous Coronary Intervention on Chronic Total Coronary Occlusions

High-Risk Morphological and Physiological Coronary Disease Attributes As Outcome Markers after Medical Treatment and Revascularization.

Percutaneous coronary revascularization versus medical therapy in chronic coronary syndromes: An updated meta‐analysis of randomized controlled trials

Long-Term Outcomes of Successful Recanalization Compared with Optimal Medical Therapy for Coronary Chronic Total Occlusions in Patients with and Without Left Ventricular Systolic Dysfunction

Evaluating the efficacy and safety of percutaneous coronary intervention (PCI) versus the optimal drug therapy (ODT) for stable coronary heart disease: a systematic review and meta-analysis

Effect of complete percutaneous revascularization on improving long-term outcomes of patients with chronic total occlusion and multi-vessel disease

Association of PCI with outcomes in stable coronary artery disease

Role of percutaneous coronary intervention in the modern-day management of chronic coronary syndrome

Two-year Clinical Outcomes of Medical Therapy Vs. Revascularization for Patients with Coronary Chronic Total Occlusion

An updated meta-analysis of optimal medical therapy with or without invasive therapy in patients with stable coronary artery disease

Assessing the Association of Appropriateness of Coronary Revascularization and 1-Year Clinical Outcomes for Patients with Stable Coronary Artery Disease in China

Predictors of Adverse Events Among Chronic Total Occlusion Patients Undergoing Successful Percutaneous Coronary Intervention and Medical Therapy

The impact of left ventricular ejection fraction on the long-term prognosis in coronary artery disease patients undergoing percutaneous coronary intervention:re-analyzed results of a prospective,multi-center and registered study

Coronary Artery Bypass Grafting and Percutaneous Coronary Intervention in Patients With Chronic Total Occlusion and Multivessel Disease